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BACKGROUND

DISCUSSION

CASE PRESENTATION

•	EM is usually associated with and secondary to an underlying cause
such as hypersensitivity to drugs, infections, autoimmune disease, or
malignancy.

•	Eosinophilic myocarditis (EM) is a rare form of myocarditis
characterized by myocardial inflammation associated with
elevated levels of blood eosinophils greater than 1.500.

•	Eosinophil mediated heart damage may present with varying
symptoms including chest pain, arrhythmias, heart failure, or death.

•	A 36 year old female with newly diagnosed nodular cystic
acne on oral minocycline, presented to the emergency
department with suspicion of an acute CVA due to
asymmetric upper extremity weakness, paresthesias, and
acute onset chest pain.

•	The mechanism of myocardial damage in EM is thought to be a
delayed type hypersensitivity reaction due to drug haptens binding to
myocardial collagen fibrils.
•	A definitive diagnosis is made by endomyocardial biopsy, however
the utility of invasive testing is limited by the patchy infiltration of
eosinophils necessitating multiple tissue samples.

•	MRI Brain demonstrated bilateral watershed infarcts involving
the anterior cerebral arteries, middle cerebral arteries, and
posterior circulation.

•	Noninvasive modalities like echocardiogram and gadolinium
enhanced CMR have gained favor in the diagnosis of EM.

•	She was found to have hyper eosinophilia on initial labs, for
which she was treated with Aspirin, Decadron, and
Colchicine due to suspected myocardial involvement on
exam and mildly elevated troponin.

•	A CMR study is consistent with the presence of myocarditis if at
least two of the three following criteria are present: regional or global
myocardial signal increase in T2-weighted images, an increased
global myocardial early gadolinium enhancement ratio between
myocardium and skeletal muscle in gadolinium enhanced T1weighted images, and at least one focal lesion with nonischemic
regional distribution in inversion recovery-prepared late gadolinium
enhanced T1-weighted images.

•	Coronary angiography revealed no significant disease.
•	Within 24 hours of treatment, her eosinophil count was
undetectable.

RESULTS

•	EM is often associated with subendocardial late gadolinium
enhancement, which can be patchy or diffuse.

•	Cardiac MRI (CMR) with contrast demonstrated sub
endocardial delayed gadolinium enhancement in a pattern
consistent with eosinophilic myocarditis.
•	The diagnosis was determined to be drug induced SLE with
E, as evidenced by her peripheral eosinophilia, elevated
troponin, CMR findings of delayed gadolinium enhancement,
and clinical improvement following corticosteroid therapy
and withdrawal of the offending agent (minocycline).

•	A failure to diagnose EM and the delay of therapy may lead to the
progression to fulminant myocarditis and irreversible myocardial
damage.
Figure 1: Cardiac MRI for patient with diagnosed eosinophilic myocarditis. (a.) T2weighted sequence in the 4-chamber view demonstrating myocardial edema. (b)
T1-weighted images in the 4-chamber view demonstrating increased global
myocardial early gadolinium enhancement. (c) Post-contrast T1-weighted images
demonstrating focal late-gadolinium enhancement in non-ischemic pattern. (d-f) T1weighted images demonstrating subendocardial delayed gadolinium enhancement
involving the basal inferior, apical inferior and apical lateral walls.

CONCLUSION

•	This case demonstrates a patient presenting with an acute CVA and
heart failure syndrome, and highlights the role of noninvasive imaging
in the diagnosis of eosinophilic myocarditis.
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